Raymond James analyst Wilma Burdis downgrades Prudential Financial (NYSE:PRU) from Strong Buy to Market Perform.
Merus Appoints Life Sciences Strategic And Financial Industry Veteran Greg Perry As Chief Financial Officer
Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the appointment of Greg Perry as the
